Download PDF
Horm Metab Res 2002; 34(9): 492-498
DOI: 10.1055/s-2002-34788
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Obesity and Weight Gain Are Associated with Increased Incidence of Hyperinsulinemia in Non-Diabetic Men

H.-M.  Lakka 1, 2 , J.  T.  Salonen 1, 2 , J.  Tuomilehto 3, 4 , G.  A.  Kaplan 5 , T.  A.  Lakka 1
  • 1Research Institute of Public Health, University of Kuopio, Kuopio, Finland
  • 2Department of Public Health and General Practice, University of Kuopio, Kuopio, Finland
  • 3Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
  • 4Department of Public Health, University of Helsinki, Finland
  • 5Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, U.S.A.
Further Information

Publication History

Received: 18 September 2001

Accepted after revision: 23 April 2002

Publication Date:
17 October 2002 (online)

Also available at
    Permissions and Reprints

Abstract

We investigated the temporal relationships between obesity, weight change and hyperinsulinemia in a population-based 4-year follow-up study of 695 middle-aged, non-diabetic, and normoinsulinemic men. Thirty-eight men developed hyperinsulinemia during the follow-up (fasting serum insulin ≥ 12.0 mU/l). In logistic regression analysis adjusting for other risk factors, men with body mass index of ≥ 26.7 kg/m2 (highest third) had a 6.6-fold (p = 0.001) risk of developing hyperinsulinemia, compared with men with body mass index of < 24.4 kg/m2 (lowest third). Correspondingly, men with waist-to-hip ratio of ≥ 0.95 (highest third) had a 3.5-fold (p = 0.028) incidence of hyperinsulinemia compared with men with waist-to-hip ratio of < 0.90 (lowest third). Weight gain in middle age and weight gain from the age of 20 years to middle age were also associated with increased risk of hyperinsulinemia. Hyperinsulinemia at baseline was not associated with weight gain during the follow-up. This prospective population-based study emphasizes the importance of avoiding obesity and weight gain during adulthood in preventing hyperinsulinemia.

Key words

Obesity - Weight Gain - Hyperinsulinemia - Insulin Resistance - Population Studies - Cohort Study

References

  • 1 Després J-P, Marette A. Obesity and insulin resistance. Epidemiologic, metabolic, and molecular aspects. In: Reaven GM, Laws A (eds). Insulin resistance. The metabolic syndrome X Humana Press Totowa, New Jersey; 1999: 51-81
    Google Scholar
  • 2 Swinburn B A, Nyomba B L, Saad M F, Zurlo F, Raz I, Knowler W C, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians.  J Clin Invest. 1991;  88 168-173
    PubMedGoogle Scholar
  • 3 Schwartz M W, Boyko E J, Kahn S E, Ravussin E, Bogardus C. Reduced insulin secretion: an independent predictor of body weight gain.  J Clin Endocrinol Metab. 1995;  80 1571-1576
    PubMedGoogle Scholar
  • 4 Valdez R, Mitchell B D, Haffner S M, Hazuda H P, Morales P A, Monterrosa A, Stern M P. Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study.  Int J Obes Relat Metab Disord. 1994;  18 85-91
    PubMedGoogle Scholar
  • 5 Hoag S, Marshall J A, Jones R H, Hamman R F. High fasting insulin levels associated with lower rates of weight gain in persons with glucose tolerance: the San Luis Valley Diabetes Study.  Int J Obes Relat Metab Disord. 1995;  19 175-180
    PubMedGoogle Scholar
  • 6 Yost T J, Jensen D R, Eckel R H. Weight regain following sustained weight reduction is predicted by relative insulin sensitivity.  Obes Res. 1995;  3 583-587
    PubMedGoogle Scholar
  • 7 Hodge A M, Dowse G K, Alberti K G, Tuomilehto J, Gareeboo H, Zimmet P Z. Relationship of insulin resistance to weight gain in non-diabetic Asian Indian, Creole, and Chinese Mauritians. Mauritius Non-communicable Disease Study Group.  Metabolism. 1996;  45 627-633
    CrossrefPubMedGoogle Scholar
  • 8 Folsom A R, Vitelli L L, Lewis C E, Schreiner P J, Watson R L, Wagenknecht L E. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts.  Int J Obes Relat Metab Disord. 1998;  22 48-54
    PubMedGoogle Scholar
  • 9 Odeleye O E, de Courten M, Pettitt D J, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children.  Diabetes. 1997;  46 1341-1345
    PubMedGoogle Scholar
  • 10 Saad M F, Knowler W C, Pettitt D J, Nelson R G, Mott D M, Bennett P H. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.  Lancet. 1989;  1 1356-1359
    PubMedGoogle Scholar
  • 11 Wing R R, Matthews K A, Kuller L H, Smith D, Becker D, Plantinga P L, Meilahn E N. Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women.  JAMA. 1992;  268 1890-1895
    PubMedGoogle Scholar
  • 12 Folsom A R, Jacobs D R, Wagenknecht L E, Winkhart S P, Yunis C, Hilner J E, Savage P J, Smith D E, Flack J M. Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study.  Am J Epidemiol. 1996;  144 235-246
    PubMedGoogle Scholar
  • 13 Srinivasan S R, Myers L, Berenson G S. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study.  Metabolism. 1999;  48 928-934
    CrossrefPubMedGoogle Scholar
  • 14 Eckel R H. Insulin resistance: an adaptation for weight maintenance.  Lancet. 1992;  340 1452-1453
    CrossrefPubMedGoogle Scholar
  • 15 Porte D, Seeley R J, Woods S C, Baskin D G, Figlewicz D P, Schwartz M W. Obesity, diabetes and the central nervous system.  Diabetologia. 1998;  41 863-881
    CrossrefPubMedGoogle Scholar
  • 16 Kahn B B, Flier J S. Obesity and insulin resistance.  J Clin Invest. 2000;  106 473-481
    CrossrefPubMedGoogle Scholar
  • 17 Salonen J T. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study.  Ann Clin Res. 1988;  20 46-50
    PubMedGoogle Scholar
  • 18 Salonen J T, Lakka T A, Lakka H-M, Valkonen V-P, Everson S A, Kaplan G A. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidaemia in middle-aged men.  Diabetes. 1998;  47 270-275
    PubMedGoogle Scholar
  • 19 Everson S A, Goldberg D E, Helmrich S P, Lakka T A, Lynch J W, Kaplan G A, Salonen J T. Weight gain and the risk of developing insulin resistance syndrome.  Diabetes Care. 1998;  21 1637-1643
    PubMedGoogle Scholar
  • 20 Lakka H-M, Lakka T A, Tuomilehto J, Sivenius J, Salonen J T. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men.  Arch Intern Med. 2000;  160 1160-1168
    CrossrefPubMedGoogle Scholar
  • 21 Salonen J T, Salonen R, Seppänen K, Rauramaa R, Tuomi-lehto J. High density lipoprotein, HDL2 and HDL3 subfractions and the risk of acute myocardial infarction: a prospective population study in Eastern Finnish men.  Circulation. 1991;  84 129-139
    CrossrefPubMedGoogle Scholar
  • 22 Salonen J T, Nyyssönen K, Tuomainen T-P, Mäenpää P H, Korpela H, Kaplan G A, Lynch J, Helmrich S, Salonen R. Increased risk of non-insulin-dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men.  BMJ. 1995;  311 1124-1127
    PubMedGoogle Scholar
  • 23 Salonen J T, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.  Circulation. 1992;  86 803-811
    CrossrefPubMedGoogle Scholar
  • 24 Lakka T A, Venäläinen J M, Rauramaa R, Salonen R, Tuomilehto J, Salonen J T. Relation of leisure-time physical activity to the risk of acute myocardial infarction in men.  N Engl J Med. 1994;  330 1549-1554
    CrossrefPubMedGoogle Scholar
  • 25 Lynch J L, Helmrich S P, Lakka T A, Kaplan G A, Cohen R D, Salonen R, Salonen J T. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men.  Arch Intern Med. 1996;  156 1307-1314
    CrossrefPubMedGoogle Scholar
  • 26 Neel J V. Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”?.  Am J Hum Genet. 1962;  14 353-362
    PubMedGoogle Scholar
  • 27 Ravussin E, Gautier J F. Metabolic predictors of weight gain.  Int J Obes Relat Metab Disord. 1999;  23 (Suppl. 1) 37-41
    CrossrefPubMedGoogle Scholar
  • 28 Lazarus R, Sparrow D, Weiss S. Temporal relations between obesity and insulin: longitudinal data from the Normative Aging Study.  Am J Epidemiol. 1998;  147 173-179
    PubMedGoogle Scholar
  • 29 Björntorp P. “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.  Arteriosclerosis. 1990;  10 493-496
    PubMedGoogle Scholar
  • 30 Bonadonna R C, Bonora E. Glucose and free fatty acid metabolism in human obesity. Relationships to insulin resistance.  Diabetes Rev. 1997;  5 21-51
    PubMedGoogle Scholar
  • 31 Carey D GP. Abdominal obesity.  Curr Opin Lipidol. 1998;  9 35-40
    PubMedGoogle Scholar
  • 32 Montague C T, O’Rahilly S. The perils of portliness: causes and consequences of visceral adiposity.  Diabetes. 2000;  49 883-888
    PubMedGoogle Scholar
  • 33 Lawrence V J, Coppack S W. The endocrine function of the fat cell-regulation by the sympathetic nervous system.  Horm Metab Res. 2000;  32 453-467
    PubMedGoogle Scholar
  • 34 Engeli S, Sharma A M. Role of adipose tissue for cardiovascular-renal regulation in health and disease.  Horm Metab Res. 2000;  32 485-499
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Garg A. The role of body fat distribution in insulin resistance. In: Reaven GM, Laws A (eds) Insulin resistance. The metabolic syndrome X. Humana Press Totowa, New Jersey; 1999: 83-96
    Google Scholar
  • 36 Campbell L V, Carey D G, Chisholm D J. Measurement of central adiposity.  A bet each way? Diabetes Care. 1996;  19 1033-1034
    PubMedGoogle Scholar
  • 37 Abate N, Garg A, Peshock R M, Stray-Gundersen J, Grundy S M. Relationships of generalized and regional adiposity to insulin sensitivity in men.  J Clin Invest. 1995;  96 88-98
    PubMedGoogle Scholar
  • 38 Seidell J C, Bouchard C. Visceral fat in relation to health: is it a major culprit or simply an innocent bystander?.  Int J Obes Relat Metab Disord. 1997;  21 626-631
    CrossrefPubMedGoogle Scholar
  • 39 World Health Organization .Obesity: Preventing and managing the global epidemic. Report of a WHO consultation.  WHO Technical Report Series, 894. World Health Organization Geneva, Switzerland; 2000
    Google Scholar
  • 40  . Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.  Arch Intern Med. 1998;  158 1855-1867
    CrossrefPubMedGoogle Scholar
  • 41 Williams S RP, Jones E, Bell W, Davies B, Bourne M W. Body habitus and coronary heart disease in men. A review with reference to methods of body habitus assessment.  Eur Heart J. 1997;  18 376-393
    PubMedGoogle Scholar
  • 42 Laakso M. How good a marker is insulin level for insulin resistance?.  Am J Epidemiol. 1993;  137 959-965
    PubMedGoogle Scholar

H.-M. Lakka, M.D., Ph.D.

Human Genomics Laboratory, Pennington Biomedical Research Center ·

Louisiana State University · 6400 Perkins Road, Baton Rouge · Louisiana 70808-4124 · USA

Phone: + 1 (225) 763 2631

Fax: + 1 (225) 763 3166

Email: lakkah@pbrc.edu